Salem Abdessalem
Sajed Mjadlah
Hichem Mahjoub
Sami Mourali
Rachid Mechemeche


Background: Percutaneous coronary intervention (PCI) has been proven to be the gold standard of reperfusion therapies in acute STelevation myocardial infarction (STEMI) in the west world. Highly trained teams and good logistical management of cathlabs may be limiting factors in developing countries and data  about outcomes following PCI in such areas is scarce.
The objectives of this study were to describe the procedural and clinical outcomes of patients undergoing PCI for STEMI at a university hospital in Tunisia and make a comparison with outcomes from the West.
Methods: We conducted a retrospective cohort study at a tertiary care university hospital in Tunis, Tunisia. A total of 208 consecutive patients undergoing PCI between January 2005 and June 2007 were reviewed. Univariate, multivariate and Kaplan meier analyses were constructed. The primary outcome was mortality: in-hospital, 30 days, and 12 months later.
Results: Cardiovascular risk factors were mainly smoking (63%) and diabetes (35.1%). The mean patient’s TIMI score was 3.8+0.2 (10% were in cardiogenic shok). Procedural success was 75.5%. Inhospital, 30 days and 12-month mortality were respectively 5.3%, 6.7% and 8.2%, comparing favorably with TIMI’s score predicted mortality and the published registries from developed countries. Multivariate predictors of in-hospital death included age>70 years, mutivessel disease and PCI failure. Multivariate predictors of 12- month death were killip score > 2 at admission (odds ratio=2.1) and PCI failure (odds ratio=2.9).
Conclusion : We conclude that, despite the logistical difficulties, excellent outcomes for acute interventional reperfusion strategy in STEMI can be achieved in a developing country, possibly similar to those seen in the West. There is a strong need for making the practice of PCI in STEMI more widespread in developing regions.





  1. Shiga T, Hagiwara N, Ogawa H, et al. Sudden Cardiac Death and Left Ventricular Ejection Fraction During Long-Term Follow-up After Acute Myocardial Infarction in the Primary Percutaneous Coronary Intervention Era. Results from the HIJAMI-II Registry. Heart 2008.
  2. Zeymer U, Gitt A, Junger C, et al. Clopidogrel in addition to aspirin reduces in-hospital major cardiac and cerebrovascular events in unselected patients with acute ST segment elevation myocardial. Thromb Haemost 2008;99:155-60.
  3. Zeller M, Steg PG, Ravisy J, et al. Relation between body mass index, waist circumference, and death after acute myocardial infarction. Circulation 2008;118:482-90.
  4. Sejersten M, Sillesen M, Hansen PR, et al. Effect on treatment delay of prehospital teletransmission of 12-lead electrocardiogram to a cardiologist for immediate triage and direct referral of patients with ST-segment elevation acute myocardial infarction to primary percutaneous coronary intervention. Am J Cardiol 2008;101:941-6.
  5. Lihioui M, Boughzala E, Ben Farhat M, et al. Distribution des facteurs de risque cardio-vasculaire chez des patients coronariens dans le Sahel tunisien. East Mediterr Health J 2007;13:536-43.
  6. Zeymer U, Gitt A, Junger C, et al. Efficacy and safety of enoxaparin in unselected patients with ST-segment elevation myocardial infarction. Thromb Haemost 2008;99:150-4.
  7. Zijlstra F. How to remove thrombus prior to stenting in patients with acute myocardial infarction? Catheter Cardiovasc Interv 2008;72:204.
  8. Zijlstra F. Should we revascularize patients with moderate coronary lesions and borderline fractional flow reserve measurements? Catheter Cardiovasc Interv 2008;71:549-50.
  9. Larosa C, Infusino F, Sgueglia GA, et al. Effect of primary percutaneous coronary intervention versus thrombolysis on ventricular arrhythmias and heart rate variability in acute myocardial infarction. Ital Heart J 2005;6:629-33.
  10. Labarere J, Bardin C, Belle L, et al. Analyse de la litterature medico-economique comparant angioplastie primaire et thrombolyse dans la prise en charge de l'infarctus aigu du myocarde. Ann Cardiol Angeiol (Paris) 2001;50:330-9.
  11. Zimarino M, Sacchetta D, Renda G, et al. Facilitated PCI: rationale, current evidence, open questions, and future directions. J Cardiovasc Pharmacol 2008;51:3-10.
  12. Boule S, Gongora A, Randriamora M, et al. Infarctus du myocarde et thrombolyse: actualites. Ann Cardiol Angeiol (Paris) 2005;54:344-52.
  13. Ben Romdhane H, Bougatef S, Skhiri H, et al. Le registre des maladies coronaires en Tunisie: organisation et premiers resultats. Rev Epidemiol Sante Publique 2004;52:558-64.
  14. Mghaieth F, Aloui H, Chabrak S, et al. Pronostic hospitalier de l'infarctus du myocarde comparaison de deux periodes a dix ans d'intervalle. Ann Cardiol Angeiol (Paris) 2006;55:241-5.
  15. Schomig A, Ndrepepa G, Mehilli J, et al. A randomized trial of coronary stenting versus balloon angioplasty as a rescue intervention after failed thrombolysis in patients with acute myocardial infarction. J Am Coll Cardiol 2004;44:2073-9.
  16. Kastrati A, Mehilli J, Nekolla S, et al. A randomized trial comparing myocardial salvage achieved by coronary stenting versus balloon angioplasty in patients with acute myocardial infarction considered ineligible for reperfusion therapy. J Am Coll Cardiol 2004;43:734-41.
  17. Motovska Z, Widimsky P, Aschermann M. The impact of gender on outcomes of patients with ST elevation myocardial infarction transported for percutaneous coronary intervention: analysis of the PRAGUE-1 and 2 studies. Heart 2008;94:e5.
  18. Applegate RJ, Sacrinty MT, Little WC, et al. Incidence of coronary stent thrombosis based on academic research consortium definitions. Am J Cardiol 2008;102:683-8.
  19. Delahaye F, Roth O, de Gevigney G. Epidemiologie des syndromes coronaires aigus. Rev Prat 2003;53:607-10.
  20. Fox KA, Anderson FA, Jr., Dabbous OH, et al. Intervention in acute coronary syndromes: do patients undergo intervention on the basis of their risk characteristics? The Global Registry of Acute Coronary Events (GRACE). Heart 2007;93:177-82.
  21. Nallamothu B, Fox KA, Kennelly BM, et al. Relationship of treatment delays and mortality in patients undergoing fibrinolysis and primary percutaneous coronary intervention. The Global Registry of Acute Coronary Events. Heart 2007;93:1552-5.
  22. Stiles MK, Dabbous OH, Fox KA. Bleeding events with antithrombotic therapy in patients with unstable angina or non-STsegment elevation myocardial infarction; insights from a large clinical practice registry (GRACE). Heart Lung Circ 2008;17:5-8.
  23. Hanania G, Cambou JP, Gueret P, et al. Management and inhospital outcome of patients with acute myocardial infarction admitted to intensive care units at the turn of the century: results from the French nationwide USIC 2000 registry. Heart 2004;90:1404-10.
  24. Belle L, Labarere J, Fourny M, et al. Comparaison de la prise en charge de l'infarctus aigu du myocarde dans les etablissements de l'arc alpin et les autres etablissements francais. Resultats de l'etude USIC 2000. Ann Cardiol Angeiol (Paris) 2005;54:310-6.
  25. Hanssen M, Monassier JP, Dujardin JJ, et al. Prise en charge des syndromes coronariens aigus dans les centres hospitaliers generaux. Resultats du registre RICA 2000. Ann Cardiol Angeiol (Paris) 2002;51:254-60.
  26. Verheugt FW. GUSTO V: the bottom line of fibrinolytic reperfusion therapy. Lancet 2001;357:1898-9.
  27. Machecourt J, Bonnefoy E, Vanzetto G, et al. Primary angioplasty is cost-minimizing compared with pre-hospital thrombolysis for patients within 60 min of a percutaneous coronary intervention center: the Comparison of Angioplasty and Pre-hospital Thrombolysis in Acute Myocardial Infarction (CAPTIM) costefficacy sub-study. J Am Coll Cardiol 2005;45:515-24.
  28. Bonnefoy E, Steg PG, Chabaud S, et al. Is primary angioplasty more effective than prehospital fibrinolysis in diabetics with acute myocardial infarction? Data from the CAPTIM randomized clinical trial. Eur Heart J 2005;26:1712-8.
  29. Topol EJ. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial. Lancet 2001;357:1905-14.
  30. Zijlstra F, Hoorntje JC, de Boer MJ, et al. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1999;341:1413-9.
  31. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003;361:13-20.
  32. Danet S, Richard F, Montaye M, et al. Unhealthy effects of atmospheric temperature and pressure on the occurrence of myocardial infarction and coronary deaths. A 10-year survey: the Lille-World Health Organization MONICA project (Monitoring trends and determinants in cardiovascular disease). Circulation 1999;100:E1-7.
  33. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, et al. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and casefatality rates in 38 populations from 21 countries in four continents. Circulation 1994;90:583-612.
  34. Gourdy P, Ruidavets JB, Ferrieres J, et al. Prevalence of type 2 diabetes and impaired fasting glucose in the middle-aged population of three French regions - The MONICA study 1995-97. Diabetes Metab 2001;27:347-58.
  35. Vlaar PJ, Svilaas T, van der Horst IC, et al. Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study. Lancet 2008;371:1915-20.
  36. Cambou JP, Simon T, Mulak G, et al. The French registry of Acute ST elevation or non-ST-elevation Myocardial Infarction (FASTMI): study design and baseline characteristics. Arch Mal Coeur Vaiss 2007;100:524-34.
  37. Danchin N, Coste P, Ferrieres J, et al. Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segmentelevation acute myocardial infarction: data from the french registry on acute ST-elevation myocardial infarction (FAST-MI). Circulation 2008;118:268-76.
  38. Stenestrand U, Lindback J, Wallentin L. Long-term outcome of primary percutaneous coronary intervention vs prehospital and inhospital thrombolysis for patients with ST-elevation myocardial infarction. JAMA 2006;296:1749-56.
  39. Svilaas T, van der Horst IC, Zijlstra F. Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS)--study design. Am Heart J 2006;151:597 e1- e7.
  40. Ting HH, Bradley EH, Wang Y, et al. Delay in presentation and reperfusion therapy in ST-elevation myocardial infarction. Am J Med 2008;121:316-23.
  41. De Luca G, Suryapranata H, Zijlstra F, et al. Symptom-onset-toballoon time and mortality in patients with acute myocardial infarction treated by primary angioplasty. J Am Coll Cardiol 2003;42:991-7.
  42. Wu EB, Arora N, Eisenhauer AC, et al. An analysis of door-toballoon time in a single center to determine causes of delay and possibilities for improvement. Catheter Cardiovasc Interv 2008;71:152-7.
  43. Svensson L, Aasa M, Dellborg M, et al. Comparison of very early treatment with either fibrinolysis or percutaneous coronary intervention facilitated with abciximab with respect to ST recovery and infarct-related artery epicardial flow in patients with acute STsegment elevation myocardial infarction: the Swedish Early Decision (SWEDES) reperfusion trial. Am Heart J 2006;151:798 e1-7.
  44. SoRelle R. Stents are the CADILLAC of care. Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications. Circulation 2002;105:e9094-5.
  45. Javaid A, Siddiqi NH, Steinberg DH, et al. Adjunct thrombus aspiration reduces mortality in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction with high-risk angiographic characteristics. Am J Cardiol 2008;101:452-6.
  46. Varbella F, Gagnor A, Luceri S, et al. Primary angioplasty and routine utilization of thrombus aspiration devices: feasibility and results in a consecutive series of 486 patients. J Cardiovasc Med (Hagerstown) 2007;8:258-64.
  47. De Luca L, Sardella G, Davidson CJ, et al. Impact of intracoronary aspiration thrombectomy during primary angioplasty on left ventricular remodelling in patients with anterior ST elevation myocardial infarction. Heart 2006;92:951-7.
  48. Burzotta F, Trani C, Romagnoli E, et al. Manual thrombusaspiration improves myocardial reperfusion: the randomized evaluation of the effect of mechanical reduction of distal embolization by thrombus-aspiration in primary and rescue angioplasty (REMEDIA) trial. J Am Coll Cardiol 2005;46:371-6.
  49. Wu TG, Zhao Q, Huang WG, et al. Effect of Intracoronary Tirofiban in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome. Circ J 2008.
  50. Danchin N, Blanchard D, Steg PG, et al. Impact of prehospital thrombolysis for acute myocardial infarction on 1-year outcome: results from the French Nationwide USIC 2000 Registry. Circulation 2004;110:1909-15.
  51. Montalescot G, Van de Werf F, Gulba DC, et al. Stenting and glycoprotein IIb/IIIa inhibition in patients with acute myocardial infarction undergoing percutaneous coronary intervention: findings from the global registry of acute coronary events (GRACE). Catheter Cardiovasc Interv 2003;60:360-7.
  52. Zijlstra F, de Boer MJ, Hoorntje JC, et al. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993;328:680-4.
  53. Spertus JA, Kettelkamp R, Vance C, et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation 2006;113:2803-9.
  54. Lev EI, Kornowski R, Vaknin-Assa H, et al. Comparison of the predictive value of four different risk scores for outcomes of patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol 2 008;102:6-11.